3 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Dose Ranging Study of ORKA-002 in Patients With Moderate-to-Severe Plaque PsoriasisPlaque PsoriasisRecruitingPhase 22026-08-10NCT07474792
Galleri® in the Medicare Population.cancer, neoplasmRecruitingNot applicable2026-05-22NCT05673018
Reentry Incentives and Support for Engagement With Contingency ManagementChemically-Induced Disorders, Narcotic-Related Disorders, Opioid Use Disorder, opiate dependence, psychiatric disorder, substance-related disorderNot yet recruitingNot applicable2026-01-07NCT07322588